Alcon (ALC) Interest & Investment Income (2009 - 2010)
Alcon (ALC) posted Interest & Investment Income of $7.0 million for Q4 2010, up 16.67% on a QoQ basis from $6.0 million in Q3 2010, and down 22.22% year-over-year from $9.0 million in Q4 2009.
Analysis
Alcon (ALC) Interest & Investment Income (2009 - 2010) Analysis & Trends
Alcon has reported Interest & Investment Income for 2 years, with the latest figure at $7.0 million in Q4 2010.
- On a quarterly basis, Interest & Investment Income fell 22.22% year-over-year to $7.0 million in Q4 2010; TTM through Dec 2010 was $29.0 million, a 36.96% decrease from a year earlier, with the FY2010 full-year figure at $29.0 million, down 36.96% from the prior year.
- Interest & Investment Income was $7.0 million for Q4 2010 at Alcon, up from $6.0 million in the prior quarter.
- The five-year high for Interest & Investment Income was $13.0 million in Q2 2009, with the low at $6.0 million in Q3 2010.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 177.43 Bn | 172.48 Bn | 7.27 Bn | 52.00 Mn |
| 2 | Intuitive Surgical | 139.20 Bn | 134.11 Bn | 1.96 Bn | - |
| 3 | Medtronic | 118.01 Bn | 109.81 Bn | 6.34 Bn | - |
| 4 | Stryker | 105.44 Bn | 101.96 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 62.90 Bn | 62.60 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 50.87 Bn | 46.72 Bn | 1.35 Bn | 30.00 Mn |
| 7 | Dexcom | 33.72 Bn | 31.77 Bn | 830.00 Mn | - |
| 8 | Resmed | 32.45 Bn | 30.98 Bn | 861.22 Mn | 20.89 Mn |
| 9 | Alcon | 31.70 Bn | 30.25 Bn | 1.68 Bn | - |
| 10 | Steris | 20.01 Bn | 19.54 Bn | 684.20 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2010 | 7.00 Mn |
| Sep 30, 2010 | 6.00 Mn |
| Jun 30, 2010 | 8.00 Mn |
| Mar 31, 2010 | 8.00 Mn |
| Dec 31, 2009 | 9.00 Mn |
| Sep 30, 2009 | 13.00 Mn |
| Jun 30, 2009 | 13.00 Mn |
| Mar 31, 2009 | 11.00 Mn |